Management consulting - strategies and insights to achieve access and commercial success.Services: strategy, market access, pricing & reimbursement, policy analysis, value positioning, segmentation, messaging, models, and market research.
Founder & Managing Partner, Bethesda, MD
● Leads a study of biotech industry-and-government (FDA) communications (pre-IND through Phase III).
● Assembled and led team that developed global payer value proposition for mRNA COVID-19 vaccine.
● Assessed OTC hearing aids' regulatory, reimbursement, and competitive landscape prior to FDA approval.
● Led team that evaluated physician behavior in a Medicare (CMS) risk-sharing pilot for at-home dialysis.
● Fractional Market Research Head - AI company (adviser to CMO, payer marketing, provider strategy).
● For phase III oncology therapy, tested unbranded medical ads on gene expression and mechanism of disease.

● Created Healthcare Practice and grew healthcare revenue from $300K to $5M.
● For UK biosimilars client, led development ofvalue narrative for market access and sustainability.
● Led rare disease value positioning for Commercial Development and Public Affairs at F50 company.
● Advised on launch of oncology CDx by providing a segmentation, personas, and message testing.

● Managed P&L $36M. Led strategy and implementation ofresearch services for biopharma brands.
● Added Market Access services; assessed acquisition targets; advised CEO to build; helped recruit and launch.
● Member, Global Leadership Team, $300M post-merger company.

● Co-managed US P&L $25M. Led sales team of SVPs and research delivery team.
● Member, Global Leadership, $220M firm; team grew 5-year CAGR by 11%; grew margins (3% to 10%).
● Member of TNS Corporate General Managers Conference (top 2% of 14,000 employees).

● Co-managed P&L $22M. Led US operations and 25 direct reports (programmers, researchers, analysts).
● Turnaround: Grew margins (-17% to +3%) by restructuring, in-sourcing, off-shoring, and automation.

● Managed P&L $10M. Led integration, strategic planning, and budget process.
● Grew the legacy Jstreetdata assets (from $2M to $10M) by growing the team, sales, and the physician database.

Venture-backed start-up that pioneered digital medical market research for data-led decision making. Co-Founder, President, and Member of the Board of Directors, Washington, DC
● Strategy & Funding: Co-wrote business plan, pitch deck and raised $2.1M (Angel, Series A, Series B).
● Tech: Recruited 15,000 physicians and 300 insurers to opt-in databases; managed Web app programmers.
● Marketing & Sales: Led brand, strategy, pricing, partnering, sales (e.g., Boston Scientific, Biogen, Pfizer).
● Exit: Negotiated sale of Jstreetdata to InterPublic Group's NFO WorldGroup (NYSE: IPG).
Continued COVANCE, HEALTH ECONOMICS AND OUTCOMES (acquired by Labcorp, now Fortrea) 1995 - 1998 Market access and reimbursement consulting in a Contract Research Organization (CRO).

Market access and reimbursement consulting in a Contract Research Organization (CRO). Washington, DC
o Increased access, affordability, and commercial success for biologics and devices by delivering GTM payer policy
strategies, including coding (ICD, J Codes, CPT and DRG), coverage, and reimbursement.
o Designed and implemented post-launch reimbursement support to resolve coverage and payment challenges.
o Led creation of pathology financial selling model for breast cancer diagnostics and trained sales force.
o Co-wrote BIO Managed Care Guide - securing coverage & reimbursement, communicating with investors & media.